Q06124 (PTN11_HUMAN) Homo sapiens (Human)

Tyrosine-protein phosphatase non-receptor type 11 UniProtKBInterProSTRINGInteractive Modelling

593 aa; Sequence (Fasta) ; (Isoform 1; Isoform 3; ) Identical sequences: Pongo abelii: A0A2J8XKS7; Pan troglodytes: K7DQU5; Macaca mulatta: H9Z053; Rhinopithecus roxellana: A0A2K6PEZ1

Sequence Features

 459Phosphocysteine intermediate
 2T -> I (in NS1; dbSNP:rs267606990) VAR_027183 dbSNP
 42T -> A (in NS1; dbSNP:rs397507501) VAR_015601 dbSNP
 58N -> K (in NS1; dbSNP:rs397507506) VAR_027184 dbSNP
 59T -> A (in NS1; dbSNP:rs886043790) VAR_066060 dbSNP
 60G -> A (in NS1; dbSNP:rs397507509) VAR_015602 dbSNP
 60G -> V (in myelodysplastic syndrome; dbSNP:rs397507509) VAR_015990 dbSNP
 61D -> G (in NS1; dbSNP:rs121918461) VAR_015603 dbSNP
 61D -> N (in NS1; dbSNP:rs397507510) VAR_015604 dbSNP
 61D -> V (in JMML; also in myelodysplastic syndrome; dbSNP:rs121918461) VAR_015991 dbSNP
 61D -> Y (in JMML; dbSNP:rs397507510) VAR_015992 dbSNP
 62Y -> D (in NS1; also in Noonan patients manifesting juvenile myelomonocytic leukemia; dbSNP:rs121918460) VAR_015605 dbSNP
 63Y -> C (in NS1; dbSNP:rs121918459) VAR_015606 dbSNP
 69E -> K (in JMML; also in myelodysplastic syndrome; dbSNP:rs397507511) VAR_015993 dbSNP
 69E -> Q (in NS1; dbSNP:rs397507511) VAR_027185 dbSNP
 71F -> K (in acute myeloid leukemia; requires 2 nucleotide substitutions) VAR_015994
 71F -> L (in myelodysplastic syndrome; dbSNP:rs397507512) VAR_015995 dbSNP
 72A -> G (in NS1; dbSNP:rs121918454) VAR_015607 dbSNP
 72A -> S (in NS1; dbSNP:rs121918453) VAR_015608 dbSNP
 72A -> T (in JMML; dbSNP:rs121918453) VAR_015996 dbSNP
 72A -> V (in JMML; dbSNP:rs121918454) VAR_015997 dbSNP
 73T -> I (in NS1; also in Noonan patients manifesting juvenile myelomonocytic leukemia; dbSNP:rs121918462) VAR_015609 dbSNP
 76E -> A (in JMML; also in myelodysplastic syndrome; dbSNP:rs121918465) VAR_015998 dbSNP
 76E -> D (in NS1; dbSNP:rs397507514) VAR_015610 dbSNP
 76E -> G (in JMML; dbSNP:rs121918465) VAR_015999 dbSNP
 76E -> K (in JMML; increases protein tyrosine phosphatase activity against CDC73; dbSNP:rs121918464) VAR_016000 dbSNP
 76E -> V (in JMML; dbSNP:rs121918465) VAR_016001 dbSNP
 79Q -> P (in NS1) VAR_027186
 79Q -> R (in NS1; dbSNP:rs121918466) VAR_015611 dbSNP
 106D -> A (in NS1; dbSNP:rs397507517) VAR_015612 dbSNP
 139E -> D (in NS1; dbSNP:rs397507520) VAR_015613 dbSNP
 256Q -> R (in NS1; dbSNP:rs397507523) VAR_027187 dbSNP
 261L -> F (in NS1; increases MAPK signaling; increases protein tyrosine phosphatase activity; changed substrate selectivity for GAB1; dbSNP:rs397507525) VAR_078101 dbSNP
 261L -> H (in NS1; increases MAPK signaling; increased protein tyrosine phosphatase activity; dbSNP:rs765642157) VAR_078102 dbSNP
 262L -> F (in NS1; increases MAPK signaling; increased protein tyrosine phosphatase activity) VAR_078103
 262L -> R (in NS1; increases MAPK signaling; increased protein tyrosine phosphatase activity; dbSNP:rs397507526) VAR_078104 dbSNP
 265R -> Q (in NS1; increases MAPK signaling; increased protein tyrosine phosphatase activity; dbSNP:rs376607329) VAR_078105 dbSNP
 279Y -> C (in NS1 and LPRD1; does not affect subcellular location; decreases protein tyrosine phosphatase activity against CDC73; dbSNP:rs121918456) VAR_015614 dbSNP
 279Y -> S (in LPRD1; dbSNP:rs121918456) VAR_027188 dbSNP
 282I -> V (in NS1; dbSNP:rs397507529) VAR_015615 dbSNP
 285F -> L (in NS1; dbSNP:rs397507531) VAR_015617 dbSNP
 285F -> S (in NS1; dbSNP:rs121918463) VAR_015616 dbSNP
 308N -> D (in NS1; common mutation; dbSNP:rs28933386) VAR_015619 dbSNP
 308N -> S (in NS1; some patients also manifest giant cell lesions of bone and soft tissue; dbSNP:rs121918455) VAR_015618 dbSNP
 309I -> V (in NS1; unknown pathological significance; dbSNP:rs201787206) VAR_015620 dbSNP
 411T -> M (in NS1; dbSNP:rs121918467) VAR_027189 dbSNP
 461A -> T (in LPRD1; dbSNP:rs121918468) VAR_027190 dbSNP
 464G -> A (in LPRD1; dbSNP:rs121918469) VAR_027191 dbSNP
 468T -> M (in LPRD1; does not affect subcellular location; decreases protein tyrosine phosphatase activity against CDC73; dbSNP:rs121918457) VAR_015621 dbSNP
 491P -> S (in NS1; increased phosphatase activity; dbSNP:rs397507539) VAR_071706 dbSNP
 498R -> L (in LPRD1; dbSNP:rs397507542) VAR_027192 dbSNP
 498R -> W (in LPRD1; reduced phosphatase activity; dbSNP:rs397507541) VAR_027193 dbSNP
 501R -> K (in NS1; dbSNP:rs397507543) VAR_015622 dbSNP
 502S -> T (in NS1; dbSNP:rs121918458) VAR_015623 dbSNP
 503G -> A (in JMML; dbSNP:rs397507546) VAR_016002 dbSNP
 503G -> R (in NS1 and JMML; JMML patient also shows growth retardation and pulmonic stenosis; dbSNP:rs397507545) VAR_016003 dbSNP
 504M -> V (in NS1; dbSNP:rs397507547) VAR_015624 dbSNP
 506Q -> P (in LPRD1; does not affect subcellular location; decreases protein tyrosine phosphatase activity against CDC73; dbSNP:rs397509345) VAR_027194 dbSNP
 506Q -> R (in NS1) VAR_027195
 510Q -> E (in NS1 and LPRD1; does not affect subcellular location; decreases protein tyrosine phosphatase activity against CDC73; dbSNP:rs397507549) VAR_076499 dbSNP
 510Q -> P (in LPRD1; dbSNP:rs121918470) VAR_027196 dbSNP
 560L -> F (in NS1; unknown pathological significance; dbSNP:rs397516797) VAR_027197 dbSNP
 6-81SH2 domain
IPR000980PF00017
 112-197SH2 domain
IPR000980PF00017
 273-519PTP type protein phosphatase
IPR000242PF00102

Sequence Alignments

Experimental structures

DescriptionOligo-stateLigandsStructureRangeDownloadAssess
Crystal structure of SHP2_SH2-CagA EPIYA_C peptide complex Heteromer
P55980;
5x7b3-220
Crystal structure of PTPN11 tandem SH2 domains in complex with a TXNIP peptide Heteromer
Q9H3M7;
UNX;5df64-220
Crystal structure of SHP2_SH2-CagA EPIYA_D peptide complex Heteromer
P55980;
5x944-219
Crystal Structure of Monobody CS1/SHP2 C-SH2 Domain Complex Heteromer
P02751;
4jeg102-217
C-SH2 domain of SHP-2 in complex with phospho-ITSM of PD-1 Heteromer
Q15116;
6r5g105-220
Structure of the N-SH2 domain of the human tyrosine-protein phosphatase non-receptor type 11 in com… Heteromer
Q15116;
6roy3-104
Structure of the N-SH2 domain of the human tyrosine-protein phosphatase non-receptor type 11 in com… Heteromer
Q15116;
6roz3-104
Crystal Structure of Monobody NSa1/SHP2 N-SH2 Domain Complex Heteromer
P02751;
4je43-103
SHP2 SH2 domain in complex with GAB1 peptide Heteromer
Q13480;
4qsy5-104
Crystal structure of the synthetic protein in complex with pY peptide Heteromer
MG;4jmg579-586
The atomic structure of SHP2 E76A mutanthomo-2-mer 6ihz2-530
Crystal structure of the tyrosine phosphatase SHP-2 with Y279C mutationmonomer EDO;GOL;PEG;PGE;4gwf2-535
Crystal structure of the tyrosine phosphatase SHP-2 with Q506P mutationmonomer EDO;GOL;4h344-537
The atomic structure of SHP2 E76A mutant in complex with allosteric inhibitor 9bmonomer 8J6;5xzr1-534
Crystal structure of the tyrosine phosphatase SHP-2 with E139D mutationmonomer EDO;PEG;4nwg2-534
Crystal structure of the tyrosine phosphatase SHP-2 with N308D mutationmonomer EDO;GOL;4nwf3-533
Crystal structure of the tyrosine phosphatase SHP-2 with D61G mutationmonomer EDO;4h1o2-532
Closed structure of active SHP2 mutant E76D bound to SHP099 inhibitormonomer 5OD;6cmr2-528
LEOPARD Syndrome-Associated SHP2/Q510E mutantmonomer 4ohi3-528
The wild-type Src homology 2 (SH2)-domain containing protein tyrosine phosphatase-2 (SHP2)monomer 4dgp3-528
LEOPARD Syndrome-Associated SHP2/Y279C mutantmonomer 4dgx3-528
LEOPARD Syndrome-Associated SHP2/G464A mutantmonomer 4ohe3-528
Closed structure of active SHP2 mutant E76K bound to SHP099 inhibitormonomer 5OD;6cms2-527
LEOPARD Syndrome-Associated SHP2/A461T mutantmonomer 4ohd2-527
LEOPARD Syndrome-Associated SHP2/Q506P mutantmonomer 4ohh3-528
Cancer-associated SHP2/T507K mutantmonomer 5bk83-527
Closed structure of inactive SHP2 mutant C459Emonomer 6cmp4-527
Structure of F285S, a Cancer-Associated Mutation of the Oncogenic Phosphatase SHP2monomer GOL;5i6v2-525
TYROSINE PHOSPHATASE SHP-2monomer CAT;2shp2-525
LEOPARD Syndrome-Associated SHP2/T468M mutantmonomer 4ohl3-526
Oxidized SHP2 forms a disulfide bond between Cys367 and Cys459monomer PO4;6atd2-525
Non-receptor Protein Tyrosine Phosphatase SHP2 in Complex with Allosteric Inhibitor SHP836monomer 5OA;PO4;5ehp3-525
Non-receptor Protein Tyrosine Phosphatase SHP2 in Complex with Allosteric Inhibitor Pyrimidinone 7monomer JE1;PO4;6md73-525
Non-receptor Protein Tyrosine Phosphatase SHP2 in Complex with Allosteric Inhibitor Imidazo-pyridin…monomer JE7;PO4;6mdd3-525
Non-receptor Protein Tyrosine Phosphatase SHP2 in Complex with Allosteric Inhibitor SHP504monomer DZS;PO4;6bmv3-525
Non-receptor Protein Tyrosine Phosphatase SHP2 in Complex with Allosteric Inhibitors SHP099 and SHP…monomer 5OD;DYV;PO4;6bmy3-525
Non-receptor Protein Tyrosine Phosphatase SHP2 in Complex with Allosteric Inhibitors SHP099 and SHP…monomer 5OD;DZS;PO4;6bmw3-525
Non-receptor Protein Tyrosine Phosphatase SHP2 in Complex with Allosteric Inhibitors SHP099 and SHP…monomer 5OD;DZV;PO4;GOL;6bmu3-525
Non-receptor Protein Tyrosine Phosphatase SHP2 in Complex with Allosteric Inhibitor SHP244monomer DZV;PO4;6bmr3-525
Non-receptor Protein Tyrosine Phosphatase SHP2 in Complex with Allosteric Inhibitor Pyrazolo-pyrimi…monomer JE4;PO4;6mdb3-525
Non-receptor Protein Tyrosine Phosphatase SHP2 in Complex with Allosteric Inhibitor SHP844monomer DYV;PO4;6bmx3-525
Non-receptor Protein Tyrosine Phosphatase SHP2 in Complex with Allosteric Inhibitor SHP099monomer 5OD;PO4;5ehr4-525
NON-RECEPTOR PROTEIN TYROSINE PHOSPHATASE SHP2 IN COMPLEX WITH ALLOSTERIC INHIBITOR Isoxazolo-pyrid…monomer JEJ;PO4;6md94-525
Non-receptor Protein Tyrosine Phosphatase SHP2 in Complex with Allosteric Inhibitor Pyrazolo-pyrimi…monomer JEA;PO4;6mdc4-525
Structure of S502P, a Cancer-Associated Mutation of the Oncogenic Phosphatase SHP2monomer 5ibm4-525
Non-receptor Protein Tyrosine Phosphatase SHP2 in Complex with Allosteric Inhibitor Pyrazolo-pyridi…monomer JED;PO4;6mda4-525
Structure of E76Q, a Cancer-Associated Mutation of the Oncogenic Phosphatase SHP2monomer 5ibs4-525
Crystal Structure of Shp2 E76K GOF Mutant in the Open Conformationmonomer GOL;6crf4-525
Crystal Structure of Shp2 E76K GOF Mutant in complex with SHP099monomer 5OD;SO4;GOL;6crg4-525
Non-receptor Protein Tyrosine Phosphatase SHP2 F285S in Complex with Allosteric Inhibitor JLR-2monomer DZJ;6bn56-521
Structure of human SHP2 without N-SH2 domainmonomer 6cmq106-527
Crystal structure of the human tyrosine phosphatase SHP2 (PTPN11) with an accessible active sitemonomer MLT;3b7o246-528
Catalytic domain of human SHP2monomer 3zm1248-525
Catalytic domain of human SHP2monomer 3zm2248-525
Catalytic domain of human SHP2monomer 3zm3248-525
Catalytic domain of human SHP2monomer 3zm0248-525
Crystal structure of protein tyrosine phosphatase Shp2 catalytic domain complex with small molecula…monomer 2WT;4pvg251-525
Co-crystal structure of SHP2 in complex with a Cefsulodin derivativemonomer 3LU;4rdd262-528
Crystal structure of the oncogenic tyrosine phosphatase SHP2 complexed with a salicylic acid-based …monomer JZG;3o5x262-527
Crystal structure of SHP2 in complex with a tautomycetin analog TTN D-1monomer B2B;3mow262-526
Structure of the SHP-2 N-SH2 domain in a 1:2 complex with RVIpYFVPLNR peptidemonomer 3tkz4-103
Structure of SHP2 N-SH2 domain in complex with RLNpYAQLWHR peptidemonomer SO4;3tl05-103

Homology models built on isoform sequence

Isoform #Oligo-stateLigandsQMEANTemplateRangeSeq id (%)ReportDownloadAssess
1monomer0.364nwg.1.A2-538
99.81
3monomer-1.595bk8.1.A3-460
99.78
1monomer-2.443ps5.1.A5-539
59.15